Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease

JAMA Neurology

Volumn 71, Issue 1, 2014, Pages 74-78

  Grau Rivera, Oriol ^a   Sánchez Valle, Raquel ^a,b   Saiz, Albert ^a,b   Molinuevo, José Luis ^a,b   Bernabé, Reyes ^c   Munteis, Elvira ^d   Pujadas, Francesc ^e   Salvador, Antoni ^f   Saura, Júlia ^g   Ugarte, Antonio ^g   Titulaer, Maarten ^b,h   Dalmau, Josep ^b,i,j   Graus, Francesc ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g Sant Joan de Déu Manresa Hospital   (Spain)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LGI1 PROTEIN, HUMAN; MEMBRANE ANTIGEN; PROTEIN; PROTEIN 14 3 3;

AGED; BIOSYNTHESIS; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NERVE CELL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

14-3-3 PROTEINS; AGED; ANTIGENS, SURFACE; AUTOANTIBODIES; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; PROSPECTIVE STUDIES; PROTEINS; RETROSPECTIVE STUDIES;

EID: 84892399456     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.4857     Document Type: Article

References (26)

1. Rosenfeld MR, Dalmau JO Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn). 2012; 18(2):366-383.
2. Rosenfeld MR, Dalmau J. Anti - NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol. 2011; 13(3):324-332.
3. Parchi P, Strammiello R, Giese A., Kretzschmar H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol. 2011; 121(1):91-112.
4. Zerr I, Kallenberg K, Summers D.M., et al Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009; 132(pt 10):2659-2668.
5. Collins SJ, Sanchez-Juan P, Masters C.L., et al Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006; 129(pt 9):2278-2287.
6. Coulthart MB, Jansen GH, Olsen E, et al Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol. 2011; 11:133. doi:10.1186/1471-2377-11-133.
7. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012; 79(14):1499-1506.
8. Saiz A, Graus F, Dalmau J., Pifarre A, Marin C, Tolosa E. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol. 1999; 46:774-777.
9. Mackay G, Ahmad K, Stone J., et al NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol. 2012; 259(9):1979-1981.
10. Fujita K, Yuasa T, Takahashi Y., et al Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol. 2012; 251(1-2):90-93.
11. Angus-Leppan H., Rudge P, Mead S., Collinge J, Vincent A. Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol. 2013; 70(7):919-922.
12. Fujita K, Yuasa T, Watanabe O., et al Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease. J Neurol. 2012; 259(10):2249-2250.
13. Hsich G, Kenney K, Gibbs C.J., Lee KH, Harrington MG The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996; 335(13):924-930.
14. Dalmau J, Gleichman AJ, Hughes E.G., et al Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12):1091-1098.
15. Irani SR, Michell AW, Lang B, et al Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011; 69(5):892-900.
16. Andrade DM, Tai P, Dalmau J., Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology. 2011; 76(15):1355-1357.
17. World Health Organization. Global surveillance, diagnosis, and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: Global Surveillance, Diagnosis, and Therapy of Human Transmissible Spongiform Encephalopathies. Geneva, Switzerland: World Health Organization; 1998:1-29.
18. Geschwind MD. Rapidly progressive dementia: prion diseases and other rapid dementias. Continuum (Minneap Minn). 2010; 16(2 dementia):31-56.
19. Chitravas N, Jung RS, Kofskey D.M., et al Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011; 70(3):437-444.
20. Flanagan EP, McKeon A, Lennon V.A., et al Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010; 85(10):881-897.
21. Geschwind MD, Tan KM, Lennon V.A., et al Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008; 65(10):1341-1346.
22. Geschwind MD, Shu H, Haman A., Sejvar JJ, Miller BL Rapidly progressive dementia. Ann Neurol. 2008; 64(1):97-108.
23. Papageorgiou SG, Kontaxis T, Bonakis A., Karahalios G, Kalfakis N, Vassilopoulos D. Rapidly progressive dementia: causes found in a Greek tertiary referral center in Athens. Alzheimer Dis Assoc Disord. 2009; 23(4):337-346.
24. Sala I, Marquié M, Sánchez-Saudinós MB, et al. Rapidly progressive dementia: experience in a tertiary care medical center. Alzheimer Dis Assoc Disord. 2012; 26(3):267-271.
25. Tan KM, Lennon VA, Klein C.J., Boeve BF, Pittock SJ Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008; 70(20):1883-1890.
26. Paterson RW, Zandi MS, Armstrong R, Vincent A., Schott JM Clinical relevance of positive voltage-gated potassium channel (VGKC) - complex antibodies: experience from a tertiary referral centre [published online June 11, 2013]. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2013-305218.